Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Technology News Journal.
Press releases published on June 12, 2025
Kratos’ Aegis Readiness Assessment Vehicle Type B (ARAV-B) Medium-Range Ballistic Missile Target Successfully Engaged, Intercepted by U.S. Guided Missile Destroyers USS Bulkeley (DDG-84) and USS Thomas Hudner (DDG-116) Using Standard Missile 3 (SM-3)
GlobeNewswire
·
June 12, 2025
SAN DIEGO, June 12, 2025 (GLOBE NEWSWIRE) -- Kratos Defense …
Integral Metals Announces Completion of High-Resolution Soil Sampling Program at the KAP Project
GlobeNewswire
·
June 12, 2025
CALGARY, Alberta, June 12, 2025 (GLOBE NEWSWIRE) -- Integral Metals Corp. (CSE: INTG | OTC: ITGLF | FSE: ZK9) (the “Company” or “Integral”) is pleased to announce the successful completion of its Phase 2 high-resolution soil sampling program at its 100%- …
CLEAR and Greenhouse Announce Partnership to Enable Candidate Verification
GlobeNewswire
·
June 12, 2025
NEW YORK, June 12, 2025 (GLOBE NEWSWIRE) -- CLEAR (NYSE: YOU), the secure identity company, today announced a new partnership with Greenhouse, trusted HR tech leader and hiring platform, to implement CLEAR1, the identity platform for businesses, to improve …
Lancaster Resources Inc. Expands Exploration in Quebec’s James Bay with Lac Iris Polymetallic Project Acquisition
GlobeNewswire
·
June 12, 2025
VANCOUVER, British Columbia, June 12, 2025 (GLOBE NEWSWIRE) -- Lancaster Resources Inc. (CSE:LCR) (OTC Pink:LANRF) (FRA:6UF) (“Lancaster”), is pleased to announce the acquisition of a 100% interest in the Lac Iris Polymetallic Project in the James Bay …
Rezolve Ai Locks In $70 Million ARR Months Ahead of Plan; Now on Track to Exceed $100 Million ARR by Year-End
GlobeNewswire
·
June 12, 2025
NEW YORK, June 12, 2025 (GLOBE NEWSWIRE) -- Rezolve Ai (NASDAQ: RZLV), the company reinventing retail through real-time AI-driven consumer engagement, today announced that it has secured more than $70 million in Annual Recurring Revenue (ARR) months ahead …
Rgenta Therapeutics Presents Preclinical Data from Lead Program, RGT-61159, a Potent and Selective Small Molecule Inhibitor of MYB RNA, Supporting its Application in the Treatment of Acute Myeloid Leukemia (AML)
GlobeNewswire
·
June 12, 2025
WOBURN, Mass., June 12, 2025 (GLOBE NEWSWIRE) -- Rgenta Therapeutics, a clinical-stage biotechnology company pioneering the development of a new class of oral small molecules targeting RNA and RNA regulation for oncology and neurological disorders, …
Third Harmonic Bio Announces Stockholder Approval of Plan of Liquidation and Dissolution, Updated THB335 Phase 1 Clinical Data, and Initiation of Sale of THB335
GlobeNewswire
·
June 12, 2025
Stockholders overwhelmingly approved liquidation and dissolution of the Company at the June 5, 2025 Annual Meeting Initial distribution currently expected in the range between approximately $5.30 and $5.35 per share of common stock, expected in the third …
Richtech Robotics’ Titan Selected as Robotics Innovation of the Year by the SupplyTech Breakthrough Awards
GlobeNewswire
·
June 12, 2025
Las Vegas, NV, June 12, 2025 (GLOBE NEWSWIRE) -- Richtech Robotics Inc. (Nasdaq: RR) (“Richtech Robotics” or the “Company”), a Nevada-based provider of AI-driven service robots, announced that its Titan robot was selected as the winner of the Robotics …
Aemetis CEO Meets with White House, Congress, and Agencies Regarding Support for Domestic Energy and Rural Communities in Budget Bill
GlobeNewswire
·
June 12, 2025
CUPERTINO, Calif., June 12, 2025 (GLOBE NEWSWIRE) -- Aemetis, Inc. (NASDAQ: AMTX), a renewable natural gas and renewable fuels company, announced today that its Chairman and CEO, Eric McAfee, has held meetings regarding support for domestic energy and …
illumin Announces Voting Results of Annual Meeting of Shareholders
GlobeNewswire
·
June 12, 2025
TORONTO and NEW YORK, June 12, 2025 (GLOBE NEWSWIRE) -- illumin Holdings Inc. (TSX:ILLM, OTCQB:ILLMF) (“illumin” or “Corporation”), the advertising technology platform that enables you to win your next customer, today announced that at its annual general …
U.S. Live Events Market worth $651.53 billion by 2032 - Exclusive Report by Coherent Market Insights
GlobeNewswire
·
June 12, 2025
Burlingame, CA, June 12, 2025 (GLOBE NEWSWIRE) -- The U.S. Live Events Market is projected to grow from USD 466.13 billion in 2025 to USD 651.53 billion by 2032 at a CAGR of 4.9% according to a new report by Coherent Market Insights. The U.S. live events …
Star Power Atlantic Adds Instagrid GO to Rental Fleet, Expanding Clean Power Options
GlobeNewswire
·
June 12, 2025
HALIFAX, Nova Scotia, June 12, 2025 (GLOBE NEWSWIRE) -- Star Power Atlantic has added the Instagrid GO to its rental fleet, bringing one of the most advanced, professional-grade portable power stations in the world to industries where quiet, dependable …
XRP Mining: It is expected that the proportion of cryptocurrency holdings in the UK will exceed that of the United States in 2025, and cloud mining will become the first choice for investors
GlobeNewswire
·
June 12, 2025
London, UK , June 12, 2025 (GLOBE NEWSWIRE) -- According to data reports, the UK has been rising rapidly in the past two years and has become the world's leading cryptocurrency holder. As of April 2025, 24% of adults surveyed in the UK hold …
Morocco Strategic Minerals Reports Sampling Results from the BMR Property
GlobeNewswire
·
June 12, 2025
MONTRÉAL, June 12, 2025 (GLOBE NEWSWIRE) -- Morocco Strategic Minerals Corporation. (TSXV: MCC) ("Morocco Strategic Minerals" or the "Corporation") is pleased to announce the results of a targeted rock sampling program completed in May 2025 on its BMR …
Corporation de Minéraux Stratégiques du Maroc publie les résultats d’échantillonnage sur la Propriété BMR
GlobeNewswire
·
June 12, 2025
MONTRÉAL, 12 juin 2025 (GLOBE NEWSWIRE) -- Corporation de Minéraux Stratégiques du Maroc (TSXV : MCC) (« Corporation de minéraux stratégiques du Maroc » ou la « Corporation ») a le plaisir de présenter les résultats d’un programme ciblé d’échantillonnage …
SoarFun Launches New Era of Web3 Interaction with Gatrifi: A Gamified, Transparent Platform for On-Chain Engagement
GlobeNewswire
·
June 12, 2025
Gibraltar, United Kingdom, June 12, 2025 (GLOBE NEWSWIRE) -- SoarFun, an emerging player at the intersection of blockchain and gaming, has officially introduced its next-generation platform built around the “Gatrifi” model — a novel fusion of gaming, …
Polyrizon Reports Promising Results Demonstrating Successful Internasal Delivery of its Innovative Hydrogel Formulation for CNS Therapeutics
GlobeNewswire
·
June 12, 2025
Ra’anana, Israel, June 12, 2025 (GLOBE NEWSWIRE) -- Polyrizon Ltd. (Nasdaq: PLRZ) (the “Company” or “Polyrizon”), a biotechnology company developing intranasal drug delivery systems, today announced encouraging preclinical results from a recent study …
Angitia Biopharmaceuticals Announces Topline Results from First in Human Study of AGA2115, A Bispecific Antibody for the Treatment of Osteogenesis Imperfecta
GlobeNewswire
·
June 12, 2025
WESTLAKE VILLAGE, Calif., June 12, 2025 (GLOBE NEWSWIRE) -- Angitia Biopharmaceuticals, a clinical-stage biotechnology company focused on the discovery and development of innovative therapeutics for serious musculoskeletal diseases, today announced topline …
Disc Medicine Presents Positive Clinical Data Updates Across Portfolio at the European Hematology Association (EHA) 2025 Annual Congress
GlobeNewswire
·
June 12, 2025
Positive updates across all programs, including longer term efficacy and safety data from the HELIOS open-label extension trial of bitopertin in erythropoietic protoporphyria (EPP), additional durability data from Phase 1b study of DISC-0974 in anemia of …
Kura Oncology and Kyowa Kirin Report Positive Updated Combination Data for Ziftomenib in Newly Diagnosed AML at 2025 European Hematology Association Congress
GlobeNewswire
·
June 12, 2025
– Encouraging clinical activity with deep responses demonstrated in the KOMET-007 trial with the combination of 600 mg ziftomenib with 7+3 in newly diagnosed patients with NPM1-m and KMT2A-r AML – – 93% (41/44) and 89% (24/27) CRc observed in NPM1-m and …